
NASDAQ:SBRA
This summary was created by AI, based on 1 opinions in the last 12 months.
Sabra Health Care REIT (SBRA-Q) is garnering attention as a top pick for 2026, driven by its strategic focus in the nursing and behavioral health sectors. Trading at an attractive price of 12 times FFO, which is significantly lower than the overall market average, it offers investors a robust dividend yield of 6.5%. The company is well-positioned to capitalize on favorable demographic trends, with earnings anticipated to grow by 5.5% this year, reflecting both strong momentum and solid fundamentals. Furthermore, its business model is resilient, showing signs of benefiting from advancements such as AI rather than being threatened by them. With a remarkable 17% increase over the past year, Sabra showcases both growth potential and stability in a competitive market.
Sabra Health Care REIT is a American stock, trading under the symbol SBRA (previously SBRA-Q on Stockchase) on the NASDAQ (SBRA). It is usually referred to as NASDAQ:SBRA or SBRA
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on SBRA (previously SBRA-Q on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Sabra Health Care REIT.
Sabra Health Care REIT was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Sabra Health Care REIT.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Sabra Health Care REIT.
Sabra Health Care REIT is followed by 6 investors on Stockchase and is a trending stock that is worth watching.
On 2026-07-02, Sabra Health Care REIT (SBRA) stock closed at a price of $20.15.
Her top pick of 2026. Trades at 12x FFO, half the market's, and pays a 6.5% dividend. They are in the nursing space (retirement and skilled), and behavioural health. Enjoys demographic winds. Earnings to grow 5.5% this year. Up 17% last year, so has momentum as well as fundamentals. Is not threatened by AI, and could even benefit Sabra.